Home > Cardiology > ACC 2019 > Pulmonary Arterial Hypertension and Venous Thromboembolism > Treatment patterns PAH have changed recently

Treatment patterns PAH have changed recently


Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22
Conference
ACC 2019
Although still a fairly rare disease, developments in treating pulmonary arterial hypertension (PAH) have not been slow and resulted in a remarkable shift in prescribing patterns. It has been shown that initial combination therapies in PAH can improve clinical outcomes in patients [1]. Although treatment guidelines may recommend certain prescribing patterns for patients, data from Ipsos’ Global PAH Therapy Monitor (TM; a retrospective medical chart review with physicians reporting on the last five PAH patients seen within the last 3 months) suggest there has been a gradual shift in recent years. In fact, more newly diagnosed patients (defined as patients who have been diagnosed within the last 12 months) are receiving a combination therapy whilst there is a decline in the prescribing of monotherapies for these patients [2]. The objective of the study by Allie et al. was to explore treatment patterns of newly diagnosed PAH patients in the SUSA vs 3 E...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on